
Episode 32: ARCH Venture Partners' Bob Nelsen
BioVenture VoiCes with Chris Garabedian
00:00
Platform vs product investing strategies
Bob explains Arch's platform approach, balancing multiple applications while staying committed long-term to promising biology.
Play episode from 01:02:28
Transcript


